Psoriasis Completed Phase 2 Trials for Bimosiamose (DB06197)

Back to Psoriasis

Also known as: Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00823693Safety and Efficacy Study of Bimosiamose Cream to Treat PsoriasisTreatment